Eur Rev Med Pharmacol Sci 2022; 26 (10): 3406-3406
DOI: 10.26355/eurrev_202205_28830

HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao

Department of Gastroenterology, Qingdao Central Hospital, Shandong, China.


The article “HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition, by Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao, published in Eur Rev Med Pharmacol Sci 2017; 21 (2): 258-265–PMID: 28165563” has been retracted by the authors due to controversial issues with author contributions.

The Publisher apologizes for any inconvenience this may cause.

HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

Free PDF Download

To cite this article

Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao
HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 10
Pages: 3406-3406
DOI: 10.26355/eurrev_202205_28830

Publication History

Published online: 27 May 2022